Analyzing multiple photos from across an oncology patient’s course of treatment with AI may be an even better predictor of survival than a single photo alone, a new Mass General Brigham study found.
Researchers behind FaceAge, which uses AI to forecast a person’s biological age, analyzed two photographs from each of 2,279 patients with cancer, taken at different time points during care, according to the April 28 study in Nature Communications.
“Deriving a Face Aging Rate from multiple, routine facial photographs allows for near real-time tracking of an individual’s health,” said co-senior and corresponding author Raymond Mak, MD, a radiation oncologist and faculty member in the AI in Medicine program at Somerville, Mass.-based Mass General Brigham, in a news release. “Our study suggests that measuring FaceAge over time may refine personalized treatment planning, improve patient counseling, and help guide the frequency and intensity of follow-up in oncology.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
